Individualized screening trial of innovative glioblastoma therapy (INSIGhT): A Bayesian adaptive platform trial to develop precision medicines for patients with glioblastoma

Brian M. Alexander, Lorenzo Trippa, Sarah Gaffey, Isabel C. Arrillaga-Romany, Eudocia Q. Lee, Mikael L. Rinne, Manmeet S. Ahluwalia, Howard Colman, Geoffrey Fell, Evanthia Galanis, John de Groot, Jan Drappatz, Andrew B. Lassman, David M. Meredith, L. Burt Nabors, Sandro Santagata, David Schiff, Mary R. Welch, Keith L. Ligon, Patrick Y. Wen

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Individualized screening trial of innovative glioblastoma therapy (INSIGhT): A Bayesian adaptive platform trial to develop precision medicines for patients with glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences